Young Dok Son

Title: Young Dok Son - Innovator in Glycoprotein Research

Introduction

Young Dok Son is a prominent inventor based in Daejeon, South Korea. He is known for his significant contributions to the field of glycoprotein research, particularly in the preparation of recombinant glycoproteins with high sialic acid content. His innovative methods have the potential to enhance the efficacy of various therapeutic proteins.

Latest Patents

Young Dok Son holds a patent for a method that focuses on preparing recombinant glycoproteins with high sialic acid content. The patent details a process involving the UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE/MNK) enzyme, where specific point mutations are introduced to maintain epimerase activity. This method leads to an increase in intracellular cytidine monophosphate (CMP)-sialic acid content, which is crucial for the production of sialylated glycoproteins. The patent emphasizes the importance of overexpressing three key genes in host cells to achieve higher sialic acid content in glycoproteins.

Career Highlights

Throughout his career, Young Dok Son has worked with esteemed institutions such as the Korea Advanced Institute of Science and Technology and LG Chem, Ltd. His work has significantly impacted the field of biotechnology, particularly in the development of therapeutic proteins.

Collaborations

Young Dok Son has collaborated with notable colleagues, including Jung Hoe Kim and Jin Young Hwang. These collaborations have further advanced research in glycoprotein production and its applications in medicine.

Conclusion

Young Dok Son's innovative methods in glycoprotein research highlight his role as a key inventor in the biotechnology field. His contributions are paving the way for advancements in therapeutic protein development, which could lead to improved treatments for various diseases.